Wangbin Sun

Title: Innovations of Wangbin Sun in Pharmaceutical Chemistry

Introduction

Wangbin Sun is a notable inventor hailing from Shanghai, China. He is recognized for his contributions to pharmaceutical chemistry, particularly for a unique compound that offers potential uses in medicine. His innovative approach to developing pyridinamine-substituted heterotricyclo compounds highlights the importance of research and invention in the pharmaceutical industry.

Latest Patents

Wangbin Sun holds a patent for "Pyridylamino Substituted Heterotricyclic Compounds, and Preparation Method and Pharmaceutical Use Thereof." This patent details a preparation method for pyridinamine-substituted heterotricyclo compounds, including a compound of formula (I), along with a pharmaceutically acceptable salt, stereoisomer, solvate, or prodrug. The patent outlines the groups defined within the formula and emphasizes their medicinal applications.

Career Highlights

Throughout his career, Wangbin Sun has worked with prominent companies in the pharmaceutical sector, including Shanghai Haiyan Pharmaceutical Technology Co., Ltd. and Yangtze River Pharmaceutical Group Co., Ltd. His experience in these organizations has contributed significantly to his understanding and development of innovative pharmaceutical products.

Collaborations

In his professional journey, Wangbin Sun has collaborated with notable individuals such as Yang Liu and Jiangwei Wang. These partnerships have enabled him to combine expertise and resources, fostering a collaborative environment conducive to innovation and efficient problem-solving.

Conclusion

Wangbin Sun's contributions to the field of pharmaceutical chemistry through his patent on pyridinamine-substituted heterotricyclo compounds mark a significant advancement in the development of new medicinal therapies. His work, along with his collaborations, underscores the value of innovation and teamwork in achieving breakthroughs in pharmaceuticals.